MabCure, Inc.
MBCI · OTC
12/31/2011 | 9/30/2011 | 6/30/2011 | 3/31/2011 | |
|---|---|---|---|---|
| Revenue | $500 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $500 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| R&D Expenses | $76 | $98 | $131 | $69 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $197 | $169 | $188 | $280 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $273 | $267 | $319 | $350 |
| Operating Income | $227 | -$267 | -$319 | -$350 |
| % Margin | 45.3% | – | – | – |
| Other Income/Exp. Net | -$11,409 | -$9 | -$93 | -$44 |
| Pre-Tax Income | -$11,182 | -$276 | -$412 | -$394 |
| Tax Expense | $13 | $9 | $102 | $63 |
| Net Income | -$11,195 | -$285 | -$514 | -$458 |
| % Margin | -2,239% | – | – | – |
| EPS | -0.18 | -0.005 | -0.008 | -0.007 |
| % Growth | -3,900% | 44.4% | -11% | – |
| EPS Diluted | -0.18 | -0.005 | -0.008 | -0.007 |
| Weighted Avg Shares Out | 63,965 | 63,465 | 63,123 | 62,844 |
| Weighted Avg Shares Out Dil | 63,965 | 63,465 | 63,123 | 62,844 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $13 | $9 | $102 | $63 |
| Depreciation & Amortization | $4 | $8 | $9 | $30 |
| EBITDA | -$11,165 | -$259 | -$310 | -$320 |
| % Margin | -2,233.1% | – | – | – |